Learn Mode
ILMN
Valuation Score
View as %
Stock Unlock
1D
1W
1M
YTD
1Y
3Y
5Y
Max
Stock Profile
- Market Cap$19.48B
- IndustryLife Sciences Tools & Services
- EPS (TTM)$5.55
- P/E (TTM)22.91
- Div & Yield--
- FCF Payout Ratio--
- P/S (TTM)4.48
- P/B7.15
- Diluted Shares153.00M
- Ex-Dividend--
- Next Earnings04-28
- Forward P/E23.35
- Payout Ratio--
- P/FCF (TTM)20.92
- FCF Yield4.78%
- Earnings Yield4.36%
- 52 Week Range
Score Card
Explore Scores Tab
3.59
Good
Valuation Model
Key Score
2.00
Bad
Management
2.00
Bad
Growth
2.00
Bad
Profitability
4.00
Good
Fin. Health
5.00
Very Good
Dividends
--
--
Analyst
1.00
Very Bad
Insider Transactions
Explore Insider Tab
Buy
Sell
Market News
Page 1 of 21
Annual & Quarterly Financial Reports, Current Reports/Updates, Ownership & Insider Transactions, Proxy Statements, Other
Form 4
Statement of changes in beneficial ownership of securities - general instructions
Filed on 2026-04-02 18:32:26
Form 4
Statement of changes in beneficial ownership of securities - general instructions
Filed on 2026-04-02 18:31:06
Form 8-K
Current report pursuant to Section 13 or 15(d)
Filed on 2026-04-02 09:09:56
Form SCHEDULE 13G/A
Unknown Form Type
Filed on 2026-03-27 09:52:48
Form 4
Statement of changes in beneficial ownership of securities - general instructions
Filed on 2026-03-09 17:06:38
Form 4
Statement of changes in beneficial ownership of securities - general instructions
Filed on 2026-03-09 17:05:22
Form 4
Statement of changes in beneficial ownership of securities - general instructions
Filed on 2026-03-09 17:04:01
Form 4
Statement of changes in beneficial ownership of securities - general instructions
Filed on 2026-03-09 17:02:43
Form 4
Statement of changes in beneficial ownership of securities - general instructions
Filed on 2026-03-09 17:01:27
Form 4
Statement of changes in beneficial ownership of securities - general instructions
Filed on 2026-03-09 16:59:17
Form 4
Statement of changes in beneficial ownership of securities - general instructions
Filed on 2026-03-09 16:56:28
Form 4
Statement of changes in beneficial ownership of securities - general instructions
Filed on 2026-03-09 16:55:02
Page 1 of 21
Financials
Explore Financials Tab
Revenue
Earnings
Free Cash Flow
Price Targets
Go to Analyst Tab
High:
$178.50
40.1%
Avg:
$139.02
9.1%
Low:
$80.80
-36.6%
Analyst Recommendations
Go to Analyst Tab
3.68
Good
29%
Strong Buy (8)
25%
Buy (7)
36%
Hold (10)
7%
Sell (2)
4%
Strong Sell (1)
About
- Website
- SEC Reports
- IPO Date2000-06-28
- IndustryLife Sciences Tools & Services
- Total Employees8,600
- ExchangeNasdaq Nms - Global Market
- Reporting CurrencyUSD
- GICSLife Sciences Tools & Services
- GICS SubLife Sciences Tools & Services
- GICS SectorHealth Care
- GICS GroupPharmaceuticals, Biotechnology & Life Sciences
Similar Stocks
Compare In Free Form
